The invention discloses a separated mRNA (
messenger Ribonucleic Acid), which comprises an mRNA for coding a new
coronavirus S1
protein, and the
amino acid sequence of the S1
protein is as shown in SEQ ID NO: 2; the invention relates to a
polyadenylic acid derivative which is characterized by further comprising one or more of the following (a)-(d): (a) a 5 '-cap structure, (b) 3'-
polyadenylic acid, (c) 5 '-UTR and (d) 3'-UTR, also disclosed are
DNA, compositions comprising the same,
liposome nanoparticles, mRNA vaccines against new
coronavirus, pharmaceutical compositions, and kits. The mRNA can be highly expressed in cells; the method is economical, efficient,
safer and efficient, the structure is more stable, the
protein expression efficiency is higher, and the new
coronavirus S1 protein can be continuously expressed. When the
liposome nano-particles / vaccines are prepared from the
liposome nano-particles / vaccines, an enough protection effect can be achieved by using an extremely small dosage, the
immunogenicity is reduced, and meanwhile, an
organism immune system can be activated to generate
humoral immunity and
cellular immunity.